Page last updated: 2024-09-03

tyrosyl-arginyl-phenylalanyl-lysinamide and guanosine 5'-o-(3-thiotriphosphate)

tyrosyl-arginyl-phenylalanyl-lysinamide has been researched along with guanosine 5'-o-(3-thiotriphosphate) in 1 studies

Compound Research Comparison

Studies
(tyrosyl-arginyl-phenylalanyl-lysinamide)
Trials
(tyrosyl-arginyl-phenylalanyl-lysinamide)
Recent Studies (post-2010)
(tyrosyl-arginyl-phenylalanyl-lysinamide)
Studies
(guanosine 5'-o-(3-thiotriphosphate))
Trials
(guanosine 5'-o-(3-thiotriphosphate))
Recent Studies (post-2010) (guanosine 5'-o-(3-thiotriphosphate))
740175,5428368

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berezowska, I; Bolan, E; Janvey, AJ; Neilan, CL; Nguyen, TM; Pasternak, GW; Schiller, PW1

Other Studies

1 other study(ies) available for tyrosyl-arginyl-phenylalanyl-lysinamide and guanosine 5'-o-(3-thiotriphosphate)

ArticleYear
Characterization of the binding of [3H][Dmt1]H-Dmt-D-Arg-Phe-Lys-NH2, a highly potent opioid peptide.
    The Journal of pharmacology and experimental therapeutics, 2003, Volume: 306, Issue:2

    Topics: Alternative Splicing; Analgesics; Animals; Binding Sites; Cattle; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Guanosine 5'-O-(3-Thiotriphosphate); Ions; Mice; Nucleotides; Oligopeptides; Opioid Peptides; Receptors, Opioid, mu; Sulfur Radioisotopes; Tritium

2003